References
Nakashima A, Yorioka N, Tanjii C et al. (2003) Bone mineral density may be related to atherosclerosis in hemodialysis patients. Osteoporos Int 14:369–373
Utermann G. (1987) Apolipoprotein E polymorphism in health and disease. Am Heart J 113:433–440
Guz G, Ozdemir FN, Sezer S, et al. (2000) Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis 36:826–836
Olmer M, Renucci JE, Planells R et al. (1997) Preliminary evidence for a role of apolipoprotein E alleles in identifying haemodialysis patients at high vascular risk. Nephrol Dial Transplant 12:691–693
Shiraki M, Shiraki Y, Aoki C et al. (1997) Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12:1438–1445
Cauley JA, Zmuda JM, Yaffe K, et al. (1999) Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk. The study of osteoporotic fractures. J Bone Miner Res 14:1175–1181
Kohlmeier M, Saupe J, Schaefer K, Asmus G. (1998) Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 62:278–281
Saupe J, Shearer MJ, Kohlmeier M. (1993) Phylloquinone transport and its influence on γ-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am J Clin Nutr 58:204–208
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liberopoulos, E.N., Elisaf, M.S. Could apolipoprotein E polymorphisms be hidden behind the relation between bone mineral density and atherosclerosis in hemodialysis patients?. Osteoporos Int 14, 957 (2003). https://doi.org/10.1007/s00198-003-1526-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-003-1526-9